Collaborators
|
Detail Information
Publications
Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover studyGilles Pomier-Layrargues
Liver Unit, Hopital Saint Luc, Centre Hospitalier de l Universite de Montreal, Montreal, Canada
Hepatology 38:238-43. 2003..In conclusion, the present study demonstrates that, under our experimental conditions, octreotide infusion combined with albumin is not effective for the treatment of HRS in cirrhotic patients...
